TBC1D1
Basic information
Region (hg38): 4:37891084-38139175
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TBC1D1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 22 | ||||
missense | 80 | 14 | 97 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 16 | 18 | ||||
Total | 0 | 0 | 98 | 37 | 5 |
Variants in TBC1D1
This is a list of pathogenic ClinVar variants found in the TBC1D1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-37902140-C-T | TBC1D1-related disorder | Benign (Aug 03, 2017) | ||
4-37902157-T-A | TBC1D1-related disorder | Uncertain significance (Feb 14, 2024) | ||
4-37902166-A-G | Inborn genetic diseases | Uncertain significance (Nov 25, 2024) | ||
4-37902189-C-T | Inborn genetic diseases | Uncertain significance (Jul 12, 2022) | ||
4-37902207-C-T | Inborn genetic diseases | Uncertain significance (Dec 17, 2021) | ||
4-37902228-G-C | TBC1D1-related disorder | Uncertain significance (Feb 14, 2024) | ||
4-37902238-G-A | TBC1D1-related disorder | Uncertain significance (Feb 22, 2024) | ||
4-37902259-C-T | TBC1D1-related disorder | Likely benign (Jun 11, 2020) | ||
4-37902271-C-A | Inborn genetic diseases | Uncertain significance (Aug 28, 2024) | ||
4-37902297-G-A | Inborn genetic diseases | Uncertain significance (Oct 29, 2021) | ||
4-37902302-A-G | Benign (Aug 03, 2017) | |||
4-37902343-A-G | Likely benign (Mar 01, 2023) | |||
4-37902351-G-C | Inborn genetic diseases | Uncertain significance (Mar 06, 2023) | ||
4-37902351-G-T | Inborn genetic diseases | Uncertain significance (Nov 18, 2022) | ||
4-37902370-G-C | Inborn genetic diseases | Uncertain significance (Mar 04, 2024) | ||
4-37902394-G-A | Inborn genetic diseases | Likely benign (Dec 03, 2024) | ||
4-37902458-C-T | Likely benign (Nov 01, 2023) | |||
4-37902465-C-T | TBC1D1-related disorder • Inborn genetic diseases | Uncertain significance (Sep 30, 2024) | ||
4-37902468-C-T | TBC1D1-related disorder | Benign (Sep 17, 2019) | ||
4-37902497-C-T | TBC1D1-related disorder | Likely benign (Jun 26, 2019) | ||
4-37902508-C-T | Inborn genetic diseases | Uncertain significance (Nov 09, 2023) | ||
4-37960475-C-G | not specified | Uncertain significance (Jun 05, 2023) | ||
4-37960483-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
4-37960484-G-A | not specified | Uncertain significance (Mar 31, 2022) | ||
4-37960505-T-C | not specified | Uncertain significance (Nov 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TBC1D1 | protein_coding | protein_coding | ENST00000261439 | 19 | 248089 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.86e-13 | 1.00 | 125641 | 1 | 106 | 125748 | 0.000426 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.755 | 623 | 678 | 0.918 | 0.0000411 | 7685 |
Missense in Polyphen | 205 | 240.33 | 0.853 | 2691 | ||
Synonymous | -0.0361 | 279 | 278 | 1.00 | 0.0000189 | 2229 |
Loss of Function | 3.46 | 31 | 59.9 | 0.518 | 0.00000352 | 634 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00135 | 0.00135 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000772 | 0.000707 |
Finnish | 0.0000929 | 0.0000924 |
European (Non-Finnish) | 0.000437 | 0.000431 |
Middle Eastern | 0.000772 | 0.000707 |
South Asian | 0.000239 | 0.000196 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: May act as a GTPase-activating protein for Rab family protein(s). May play a role in the cell cycle and differentiation of various tissues. Involved in the trafficking and translocation of GLUT4-containing vesicles and insulin-stimulated glucose uptake into cells (By similarity). {ECO:0000250}.;
- Pathway
- AMPK signaling pathway - Homo sapiens (human);Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Vesicle-mediated transport;Membrane Trafficking;Translocation of GLUT4 to the plasma membrane
(Consensus)
Recessive Scores
- pRec
- 0.206
Intolerance Scores
- loftool
- 0.881
- rvis_EVS
- 0.01
- rvis_percentile_EVS
- 54.16
Haploinsufficiency Scores
- pHI
- 0.163
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.456
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.615
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tbc1d1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); normal phenotype;
Gene ontology
- Biological process
- intracellular protein transport;regulation of protein localization;membrane organization;activation of GTPase activity;regulation of cilium assembly
- Cellular component
- nucleus;cytosol
- Molecular function
- GTPase activator activity;protein binding;Rab GTPase binding